Brochure | February 22, 2021

Synthetic Control Arm®: The Smart External Control Arm Solution

Sponsors often experience unique and significant challenges with randomized trials:

  • Randomization is not always possible due to ethical reasons or rarity of a disease
  • Noncompliant use of the investigational agent, or similiar agent in the same class, by control patients
  • Slow recruitment due to unacceptability of control treatment to patients
  • Deciding which are the most promising products to advance in pipeline

Acorn AI by Medidata is uniquely positioned at the nexus of historical clinical trial and real world data; with a platform that integrates disparate datasets. Our Synthetic Control Arm® (SCA) solution can bring significant value to your company’s trials and ultimately help to increase the probability of overall success of your key pipeline assets. SCA supports trial design choices to enhance or replace control arms for registrational trials or early phase studies. This improves decision making, accelerate enrollment and reduce clinical development costs.

VIEW THE BROCHURE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: